Dose escalation and expansion phase I studies with the tumour-targeting antibody-tumour necrosis factor fusion protein L19TNF plus doxorubicin in patients with advanced tumours, including sarcomas
Titel:
Dose escalation and expansion phase I studies with the tumour-targeting antibody-tumour necrosis factor fusion protein L19TNF plus doxorubicin in patients with advanced tumours, including sarcomas
Auteur:
Schliemann, Christoph Hemmerle, Teresa Berdel, Andrew F. Angenendt, Linus Kerkhoff, Andrea Hering, Jan P. Heindel, Walter Hartmann, Wolfgang Wardelmann, Eva Chawla, Sant P. de Braud, Filippo Lenz, Georg Neri, Dario Kessler, Torsten Berdel, Wolfgang E.